Related Experiment Video
Updated: Oct 4, 2025

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
Published on: October 20, 2014
RUNX1 overexpression triggers TGF-β signaling to upregulate p15 and thereby blocks early hematopoiesis by inducing
Wencui Sun1, Danying Yi1, Lijiao Zhu1
1Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chengdu 610052, China.
Abstract:
p15INK4b (cyclin-dependent kinase inhibitor 2B, CDKN2B, p15), a cyclin-dependent kinase inhibitor (CKI) belonging to the INK4 family, plays an important role in hematopoiesis. Its expression level was positively related to the blockage effects of RUNX1b at the early stage. Experiments using human embryonic stem cell (hESC) lines with inducible p15 expression suggested that p15 overexpression can significantly decrease the proportion of KDR+ cells in S and G2-M stages 4 days after induction from day 0. Moreover, p15 overexpression from the early stage can decrease production of CD34highCD43- cells and their derivative populations, but not CD34lowCD43- cells. These effects were weakened if induction was delayed and disappeared if induction started after day 6. All these effects were counteracted by inhibition of TGF-β signaling. TGF-β1 stimulation elicited similar effects as p15 overexpression. RUNX1 overexpression and activation of the TGF-β signaling pathway upregulate the expression of p15, which is partially responsible for blockade of hematopoiesis and relevant to a change in the cell cycle status. However, it is possible that other mechanisms are involved in the regulation of hematopoiesis.
Insights
p15INK4b (CDKN2B) overexpression in human embryonic stem cells inhibits hematopoiesis by affecting cell cycle progression and cell populations. TGF-β signaling is crucial for these p15INK4b-mediated effects.
Area of Science:
- Hematopoiesis research
- Stem cell biology
- Cell cycle regulation
Background:
- p15INK4b (CDKN2B) is a cyclin-dependent kinase inhibitor (CKI) in the INK4 family.
- p15INK4b plays a significant role in regulating hematopoiesis.
Purpose of the Study:
- To investigate the role of p15INK4b in human embryonic stem cell (hESC) hematopoiesis.
- To explore the relationship between p15INK4b, RUNX1, and TGF-β signaling in hematopoiesis.
Main Methods:
- Utilized hESC lines with inducible p15INK4b expression.
- Analyzed cell cycle status (KDR+ cells) and hematopoietic progenitor populations (CD34, CD43).
- Investigated the impact of delayed p15INK4b induction and TGF-β signaling inhibition.
Main Results:
- p15INK4b overexpression decreased KDR+ cells in S and G2-M stages and reduced CD34highCD43- cell production.
- These effects were time-dependent, diminishing with delayed induction.
- TGF-β1 stimulation mimicked p15INK4b overexpression effects, and inhibition of TGF-β signaling counteracted them.
- RUNX1 and TGF-β signaling activation upregulate p15INK4b, partially blocking hematopoiesis.
Conclusions:
- p15INK4b plays a critical role in regulating hESC hematopoiesis, influencing cell cycle and progenitor cell production.
- The TGF-β signaling pathway is integral to p15INK4b-mediated hematopoietic regulation.
- RUNX1 and TGF-β signaling contribute to p15INK4b-induced hematopoietic blockade, though other mechanisms may also be involved.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
Lineage Commitment
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Regulation of Hematopoietic Stem Cells

